ESR1 and endometrial carcinoma: Overexpression of ephrin-B2 detected in ER (+)/PR (+) endometrial carcinomasNo significant differences in ephrin-B2 expression between ER (-)/PR (-) endometrial carcinoma cases and control specimens reportedEphrin-B2 overexpression associated with er expression